๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Predicting bacteremia and bacteremic mortality in liver transplant recipients

โœ Scribed by Nina Singh; David L. Paterson; Timothy Gayowski; Marilyn M. Wagener; Ignazio R. Marino


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
93 KB
Volume
6
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis


Predictors of bacteremia and mortality in bacteremic liver transplant recipients were prospectively assessed. One hundred eleven consecutive episodes of fever or infections were documented in 59 patients over a 4-year period. Forty-nine percent (29 of 59 patients) of the patients had bacteremia, 39% (23 of 59 patients) had nonbacteremic infections, and 12% (7 of 59 patients) had fever of noninfectious cause. Primary (catheter-related) bacteremia (31%; 9 of 29 patients), pneumonia (24%; 7 of 29 patients), abdominal and/or biliary infections (14%; 4 of 29 patients), and wound infections (10%; 3 of 29 patients) were the predominant sources of bacteremia. Diabetes mellitus (odds ratio, 6.9; P โ€ซุโ€ฌ .03) and serum albumin level less than 3.0 mg/dL (odds ratio, 0.14; P โ€ซุโ€ฌ .02) were independently significant predictors of bacteremia compared with nonbacteremic infections. Mortality at 14 days was 28% (8 of 29 patients) in those with bacteremia compared with 4% (1 of 23 patients) in those with nonbacteremic infections and 0% (0 of 7) in patients with fever of noninfectious cause (P โ€ซุโ€ฌ .03). Intensive care unit stay at the time of bacteremia (100% v 47%; P โ€ซุโ€ฌ .005), absence of chills (0% v 53%; P โ€ซุโ€ฌ .005), lower temperature at the onset of bacteremia (99.2ะŠF v 101.5ะŠF; P โ€ซุโ€ฌ .009), lower maximum temperature during the course of bacteremia (99.3ะŠF v 102ะŠF, P โ€ซุโ€ฌ .008), greater serum bilirubin level (7.6 v 1.5 mg/dL; P โ€ซุโ€ฌ .024), presence of abnormal blood pressure (80% v 16%; P โ€ซุโ€ฌ .0013), and greater prothrombin time (15.6 v 13.3 seconds; P โ€ซุโ€ฌ .013) were significantly predictive of greater mortality in the bacteremic patients. These data have implications for discerning the likelihood of bacteremia and initiation of empiric antibiotics pending cultures. Lack of febrile response in bacteremic liver transplant recipients portended a poorer outcome.


๐Ÿ“œ SIMILAR VOLUMES


Posttransplant bacteremia in adult livin
โœ Taku Iida; Toshimi Kaido; Shintaro Yagi; Atsushi Yoshizawa; Koichiro Hata; Masak ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 171 KB ๐Ÿ‘ 1 views

Infectious complications such as bacteremia after living donor liver transplantation (LDLT) are associated with significant morbidity and mortality. We retrospectively analyzed the frequency and characteristics of posttransplant bacteremia in 181 adult LDLT recipients between April 2006 and November

Adherence in liver transplant recipients
โœ Patrizia Burra; Giacomo Germani; Francesca Gnoato; Silvia Lazzaro; Francesco Pao ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB

Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to i

Antifungal prophylaxis in liver transpla
โœ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Hepatitis B in liver transplant recipien
โœ Robert G. Gish; Timothy McCashland ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire

Smoking behavior in liver transplant rec
โœ Frans van der Heide; Gerard Dijkstra; Robert J. Porte; Jan H. Kleibeuker; Elizab ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB

Long-term morbidity and survival after orthotopic liver transplantation (OLT) are to a large degree determined by cardiovascular disease and cancer. Tobacco use is a well-known risk factor for both. The aim of this study was to examine smoking behavior before and after OLT and to define groups at ri